Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
ID: 344078Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $75K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/344078

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-24-005.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), has announced a Limited Competition Small Grant Program aimed at supporting recipients of NHLBI K01, K08, K23, and K25 awards. This funding opportunity (R03) is designed to provide small grants to enhance research capabilities and facilitate the transition of K awardees into independent research roles, with projects focusing on pilot studies, proof of concept studies, and methodological innovations that can be completed within two years. The total budget commitment for this initiative is up to $4.8 million for FY2025 and FY2026, with individual grants capped at $75,000 per year. Interested applicants can find more information and apply by the deadline of January 7, 2026, by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-24-005.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-HL-24-005.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Heart, Lung, and Blood Institute (NHLBI), has announced a Limited Competition Small Grant Program for recipients of NHLBI K01, K08, K23, and K25 awards. This funding opportunity (R03) aims to provide small grants to enhance research capabilities and support early-stage independent investigations that can be completed within two years with limited resources. Eligible applicants include current and recently completed K award recipients, with projects focusing on pilot studies, proof of concept studies, and methodological innovations. Funding announcements detail a total budget commitment of up to $4.8 million for FY2025 and FY2026, with individual grants capped at $75,000 per year. Applications will undergo a rigorous peer review process assessing significance and potential impact. Essentially, this initiative seeks to facilitate the transition of K awardees into independent research roles, ultimately bolstering the nation's biomedical research workforce by supporting diverse and capable investigators.
    Similar Opportunities
    Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has announced a Limited Competition Small Grant Program aimed at supporting current K01, K08, K23, and K25 award recipients. This program is designed to facilitate the transition of these early-career researchers to fully independent investigator status by providing funding for small, self-contained research projects, with grants offering up to $75,000 in direct costs per year for a maximum project period of two years. The initiative encourages applicants to demonstrate their growing independence and ability to secure future funding, particularly for R01 applications, while adhering to NIH policies regarding human subjects and clinical trials. Interested applicants must submit their proposals by September 7, 2025, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition Small Grant Program (R03) aimed at supporting recipients of K01, K08, K23, and K25 awards from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This program allows eligible awardees, specifically those in their second to fourth award year who do not yet hold independent R01 grants, to request up to $100,000 in direct costs over a two-year period to enhance their research capabilities, focusing on pilot studies, methodology development, and secondary data analysis, while explicitly excluding clinical trials. The initiative is designed to foster the development of early-career scientists and strengthen the research landscape by generating additional publications and data necessary for future R01 grant applications. Interested applicants must submit their proposals by February 19, 2025, and can find more information and application guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition Small Grant Program aimed at supporting recipients of the Special Emphasis Research Career Award (SERCA) K01 who have completed the first two years of their award. This program provides funding of up to $75,000 in direct costs over a maximum period of two years to facilitate small-scale research projects, excluding clinical trials, thereby assisting awardees in transitioning to independent research roles. The initiative is part of NIH's commitment to enhancing the diversity of research talent and advancing biomedical research, particularly in veterinary science. Interested applicants from eligible organizations must adhere to submission guidelines, with applications accepted until May 7, 2026; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-127.html.
    NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NHLBI Career Transition Award (K22), a federal grant aimed at supporting postdoctoral fellows and doctoral-level researchers transitioning from intramural NIH research to independent extramural research. This program features a two-phase support structure: an up to two-year mentored intramural phase followed by a three-year extramural phase, contingent upon a successful review of the awardee's research progress. The grant is designed to cultivate future researchers capable of addressing critical health-related questions and enhancing the scientific community, with an emphasis on diversity and inclusion of underrepresented groups. Interested applicants must have a relevant doctoral degree and adhere to stringent application instructions, with proposals due starting September 12, 2024. For further details, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and the opportunity is open until July 12, 2027.
    Limited Competition: Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Heart, Lung, and Blood Institute (NHLBI), has announced a Limited Competition Funding Opportunity titled "Physician Scientist Transition to Independence in Blood Science Research" (R00 - Clinical Trial Optional). This initiative aims to support the transition of outstanding blood science researchers with clinical doctorate degrees from mentored research positions to independent faculty roles, providing up to three years of funding for innovative research in blood science. The program is particularly focused on enhancing the scientific workforce by promoting diversity and fostering independent research careers that address critical health challenges in hematology. Interested applicants must submit their proposals by March 28, 2025, with a total funding ceiling of $250,000 available for new awards, and can direct inquiries to grantsinfo@nih.gov for further information.
    NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NHLBI Career Transition Award (K22) aimed at supporting postdoctoral fellows and research trainees in transitioning their research programs to extramural institutions as junior investigators. This grant provides a structured five-year program, which includes a mentored intramural phase of up to two years followed by an independent extramural phase lasting three years, contingent upon successful progress during the mentored phase. The program is designed to cultivate a diverse pool of skilled investigators to meet national biomedical research needs, with eligibility requirements including a doctoral degree and a maximum of five years of postdoctoral research experience within the NHLBI. Interested applicants should note that the application deadline is July 12, 2027, and they can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found in the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-209.html.
    Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program, designated as R03 Clinical Trial Optional. This funding opportunity aims to support KL2/K12 scholars and recipients of diversity and re-entry supplements in their transition to independent research roles by funding small, innovative, self-contained projects in translational science, with a maximum budget of $50,000 per year over a two-year period. The initiative is designed to enhance the capabilities of emerging researchers in addressing inefficiencies in translating research into clinical applications, engaging underrepresented populations, and improving data accessibility through innovative technologies. Applications will be accepted starting January 19, 2024, with multiple deadlines leading up to October 20, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) to support small-scale research projects that can be completed in a short timeframe with limited resources. This program is designed to fund various types of research, including pilot studies, secondary data analysis, and the development of research methodologies, while explicitly excluding clinical trials. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and tribal governments, with each application allowed to request up to $50,000 per year for a project duration not exceeding two years. Interested parties should submit their applications electronically via Grants.gov by January 7, 2025, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for any inquiries regarding the funding announcement.
    Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), is offering a Small Research Grant Program (R03) aimed at fostering the next generation of researchers in Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This program supports innovative projects that enhance understanding, diagnosis, treatment, and care strategies for AD/ADRD, while also promoting workforce diversity and addressing health disparities in this field. Grants of up to $100,000 for a duration of two years are available, with a total of 12 awards expected for fiscal year 2024, amounting to $1.8 million in funding. Interested applicants must be affiliated with eligible organizations and are encouraged to submit their applications by March 16, 2026, with inquiries directed to grantsinfo@nih.gov for further information.
    NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NICHD Small Research Grant Program (R03), which supports small clinical trials focused on basic experimental studies involving human participants. This funding opportunity aims to enhance understanding of fundamental phenomena without immediate application towards products or processes, aligning with the NICHD's mission in human development, behavior, and health. Grants are available for up to $50,000 in direct costs per year, with a maximum project duration of two years, and applications must be submitted by January 7, 2025. Interested applicants can find more information and application details at the NIH website or contact the NIH OER Webmaster at grantsinfo@nih.gov for assistance.